Similar articles for PMID: 19074868

Year	Number of Results
1999	1
2003	1
2004	3
2005	3
2006	2
2007	7
2008	9
2009	6
2010	10
2011	13
2012	6
2013	5
2014	4
2015	10
2016	2
2018	5
2019	1
2020	1
2021	2
2024	0

1

Negative Regulation of AKT Activation by BRCA1.

Xiang T, Ohashi A, Huang Y, Pandita TK, Ludwig T, Powell SN, Yang Q. Xiang T, et al. Cancer Res. 2008 Dec 15;68(24):10040-4. doi: 10.1158/0008-5472.CAN-08-3009. Cancer Res. 2008. PMID: 19074868 Free PMC article.

2

Targeting the Akt/mTOR pathway in Brca1-deficient cancers.

Xiang T, Jia Y, Sherris D, Li S, Wang H, Lu D, Yang Q. Xiang T, et al. Oncogene. 2011 May 26;30(21):2443-50. doi: 10.1038/onc.2010.603. Epub 2011 Jan 17. Oncogene. 2011. PMID: 21242970 Free PMC article.

3

Histone methyltransferase EZH2 induces Akt-dependent genomic instability and BRCA1 inhibition in breast cancer.

Gonzalez ME, DuPrie ML, Krueger H, Merajver SD, Ventura AC, Toy KA, Kleer CG. Gonzalez ME, et al. Cancer Res. 2011 Mar 15;71(6):2360-70. doi: 10.1158/0008-5472.CAN-10-1933. Cancer Res. 2011. PMID: 21406404 Free PMC article.

4

BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.

Blanchard Z, Paul BT, Craft B, ElShamy WM. Blanchard Z, et al. Breast Cancer Res. 2015 Jan 13;17(1):5. doi: 10.1186/s13058-014-0512-9. Breast Cancer Res. 2015. PMID: 25583261 Free PMC article.

5

Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1.

Hinton CV, Fitzgerald LD, Thompson ME. Hinton CV, et al. Exp Cell Res. 2007 May 15;313(9):1735-44. doi: 10.1016/j.yexcr.2007.03.008. Epub 2007 Mar 15. Exp Cell Res. 2007. PMID: 17428466 Free PMC article.

6

BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells.

Chock KL, Allison JM, Shimizu Y, ElShamy WM. Chock KL, et al. Cancer Res. 2010 Nov 1;70(21):8782-91. doi: 10.1158/0008-5472.CAN-10-1352. Epub 2010 Oct 12. Cancer Res. 2010. PMID: 20940403

7

Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer.

Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, Ng TT, Karadedou CT, Millour J, Ip YC, Cheung YN, Sunters A, Chan KY, Lam EW, Khoo US. Chen J, et al. PLoS One. 2010 Aug 20;5(8):e12293. doi: 10.1371/journal.pone.0012293. PLoS One. 2010. PMID: 20808831 Free PMC article.

8

Inhibition of FOXO1/3 promotes vascular calcification.

Deng L, Huang L, Sun Y, Heath JM, Wu H, Chen Y. Deng L, et al. Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):175-83. doi: 10.1161/ATVBAHA.114.304786. Epub 2014 Nov 6. Arterioscler Thromb Vasc Biol. 2015. PMID: 25378413 Free PMC article.

9

BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG, Tomita YA, Rosen EM. Ma Y, et al. Mol Endocrinol. 2010 Jan;24(1):76-90. doi: 10.1210/me.2009-0218. Epub 2009 Nov 3. Mol Endocrinol. 2010. PMID: 19887647 Free PMC article.

10

PKCtheta promotes c-Rel-driven mammary tumorigenesis in mice and humans by repressing estrogen receptor alpha synthesis.

Belguise K, Sonenshein GE. Belguise K, et al. J Clin Invest. 2007 Dec;117(12):4009-21. doi: 10.1172/JCI32424. J Clin Invest. 2007. PMID: 18037997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year